Menu
Currency
GWAS Study

Genetic analysis in African American children supports ancestry specific neuroblastoma susceptibility.

Testori A, Vaksman Z, Diskin SJ et al.

35131881 PubMed ID
GWAS Study Type
3619 Participants
106 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TA
Testori A
VZ
Vaksman Z
DS
Diskin SJ
HH
Hakonarson H
CM
Capasso M
IA
Iolascon A
MJ
Maris JM
DM
Devoto M
Chapter II

Abstract

Summary of the research findings

Neuroblastoma is rarer in African American (AA) children compared with American children of European descent. AA children affected with neuroblastoma, however, more frequently develop the high-risk form of the disease.

629 African American cases, 2,990 African American controls

Chapter III

Study Statistics

Key metrics and study information

3619
Total Participants
GWAS
Study Type
No
Replicated
African American or Afro-Caribbean
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.